Galafold Safe, Effective at Reducing Heart Damage: Real-life Study

Galafold Safe, Effective at Reducing Heart Damage: Real-life Study

327109

Galafold Safe, Effective at Reducing Heart Damage: Real-life Study

Galafold (migalastat) is generally safe and significantly reduces disease-associated heart enlargement in Fabry disease patients carrying Galafold-amenable mutations, according to two-year data from a real-life, multicenter study in Germany. These benefits were generally similar between patients who had previously received standard enzyme replacement therapy (ERT) and those who had not. Patients’ kidney function did show a significant decline over the two years, particularly among patients on certain medications for high blood pressure (hypertension), suggesting they had…

You must be logged in to read/download the full post.